Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.46B | 13.01B | 17.59B | 18.38B | 12.59B | Gross Profit |
3.89B | 3.50B | 5.47B | 7.32B | 5.45B | EBIT |
12.00M | -1.38B | 75.00M | 1.52B | 1.32B | EBITDA |
507.00M | -1.33B | 574.00M | 1.85B | 1.57B | Net Income Common Stockholders |
67.00M | -2.07B | 3.00M | 1.01B | 834.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.34B | 1.17B | 1.25B | 1.00B | 4.45B | Total Assets |
6.18B | 7.80B | 9.91B | 10.88B | 9.11B | Total Debt |
428.00M | 1.44B | 1.41B | 1.42B | 1.15B | Net Debt |
-917.00M | 275.00M | 168.00M | 423.00M | -3.31B | Total Liabilities |
1.83B | 3.54B | 3.60B | 4.59B | 4.36B | Stockholders Equity |
4.35B | 4.26B | 6.31B | 6.29B | 4.76B |
Cash Flow | Free Cash Flow | |||
1.16B | -192.00M | 231.00M | -4.12B | 1.17B | Operating Cash Flow |
1.35B | 246.00M | 840.00M | -3.24B | 1.58B | Investing Cash Flow |
-205.00M | -371.00M | -621.00M | -964.00M | -421.00M | Financing Cash Flow |
-1.01B | 44.00M | 5.00M | 738.00M | 2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥3.88B | 5.33 | 1.55% | -0.55% | -6.93% | ||
74 Outperform | ¥4.62B | 9.21 | 1.94% | 5.48% | 72.23% | ||
65 Neutral | ¥8.32B | 8.04 | 5.07% | 8.65% | 84.06% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
58 Neutral | ¥10.57B | 9.10 | 3.37% | -5.57% | -1.82% | ||
55 Neutral | ¥7.52B | 119.08 | ― | -5.23% | 93.21% | ||
45 Neutral | ¥4.72B | 53.02 | 4.51% | -2.39% | -194.34% |
BALMUDA Inc. reported a decline in net sales and increased losses for the first quarter of 2025, with net sales falling by 7.4% compared to the previous year. The company anticipates a slight recovery in net sales for the full year, projecting a modest increase of 0.3%, but continues to face challenges in achieving profitability.